TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer

Wei Xu(Jiangsu Province Hospital), Jianwei Zhou(Second Affiliated Hospital of Zhejiang University)

Cell Death and Disease

February 13, 2014

10.1038/cddis.2014.27

Cited by 84

Related Papers

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|390

JAK2-binding long noncoding RNA promotes breast cancer brain metastasis

|Journal of Clinical Investigation|2017|231

JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells

|Cell Death and Disease|2014|58

JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis

|Journal of Experimental & Clinical Cancer Research|2020|55

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib

|Cell & Bioscience|2015|50